Market LIVE
Published markets; coverage varies by country
Product profile · United States

LIFYORLI (COPACKAGED)

 ·  Patent Litigation & Settlement History ↓

IngredientRELACORILANT
Application typeNDA
Application220641
Product001
Dosage formCAPSULE
RouteORAL
Strength100MG;25MG
Approval date2026-03-25
Marketing statusPrescription
Status event—
ApplicantCORCEPT THERAP
Product source

Current GenericRadar decision

Year2033
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typePATENT
Anchor date2033-05-24
Patent anchor2033-05-24
Exclusivity anchor2031-03-25
Protection date2041-12-22
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2033. Anchor type: PATENT. Patent anchor: 2033-05-24. Exclusivity anchor: 2031-03-25. Anchor date: 2033-05-24. Patent tail: yes. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
104563922033-05-24U U-4457NNU
English description not available.
———
104563922033-05-24ORANGE_BOOK U-4457NNU
English description not available.
———
115769072033-05-24DS/DP/U U-4457YNTRUE_DS
English description not available.
———
115769072033-05-24DS/DP/U U-4458YNTRUE_DS
English description not available.
———
115769072033-05-24DS/DP/U U-4459YNTRUE_DS
English description not available.
———
115769072033-05-24ORANGE_BOOK U-4457;U-4458;U-4459YNTRUE_DS
English description not available.
———
88597742033-05-24DS/DP —YNTRUE_DS
English description not available.
———
88597742033-05-24ORANGE_BOOK —YNTRUE_DS
English description not available.
———
92730472033-05-24U U-4457NYU
English description not available.
———
92730472033-05-24U U-4458NYU
English description not available.
———
92730472033-05-24U U-4459NYU
English description not available.
———
92730472033-05-24ORANGE_BOOK U-4457;U-4458;U-4459NYU
English description not available.
———
119256262039-12-18DP —NNDP
English description not available.
———
119256262039-12-18ORANGE_BOOK —NNDP
English description not available.
———
125148492039-12-18DP —NNDP
English description not available.
———
125148492039-12-18ORANGE_BOOK —NNDP
English description not available.
———
114647642040-04-14DP —NNDP
English description not available.
———
114647642040-04-14ORANGE_BOOK —NNDP
English description not available.
———
112851452041-05-26U U-4459NNU
English description not available.
———
112851452041-05-26U U-4457NNU
English description not available.
———
112851452041-05-26U U-4458NNU
English description not available.
———
112851452041-05-26ORANGE_BOOK U-4457;U-4458;U-4459NNU
English description not available.
———
125890942041-05-26U U-4457NNU
English description not available.
———
125890942041-05-26U U-4458NNU
English description not available.
———
125890942041-05-26U U-4459NNU
English description not available.
———
125890942041-05-26ORANGE_BOOK U-4457;U-4458;U-4459NNU
English description not available.
———
121520282041-12-22DP/U U-4459NNPROCESS
English description not available.
———
121520282041-12-22DP/U U-4458NNPROCESS
English description not available.
———
121520282041-12-22DP/U U-4457NNPROCESS
English description not available.
———
121520282041-12-22ORANGE_BOOK U-4457;U-4458;U-4459NNPROCESS
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2026-03-252031-03-25English description not available.YY2031-03-25—Source
NCE2026-03-252031-03-25English description not available.YY2031-03-25
NCE
Full coverage date: 2031-03-25
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (12)
TypeDateRoleBasisSource
PATENT2033-05-24HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2033-05-24CANONICAL_ANCHOREnglish description not available.Source
PATENT2033-05-24CANONICAL_ANCHOREnglish description not available.Source
PATENT2033-05-24CANONICAL_ANCHOREnglish description not available.Source
PATENT2039-12-18FTO_TAILEnglish description not available.Source
PATENT2039-12-18FTO_TAILEnglish description not available.Source
PATENT2040-04-14FTO_TAILEnglish description not available.Source
PATENT2041-05-26FTO_TAILEnglish description not available.Source
PATENT2041-05-26FTO_TAILEnglish description not available.Source
PATENT2041-12-22FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2033-05-24CANONICAL_DECISIONEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.